Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Lotus Pharmaceuticals Long Term Debt 2010-2011 | LTUS

Lotus Pharmaceuticals long term debt from 2010 to 2011. Long term debt can be defined as the sum of all long term debt fields.
  
Lotus Pharmaceuticals Annual Long Term Debt
(Millions of US $)
2010 $5
2009 $5
Lotus Pharmaceuticals Quarterly Long Term Debt
(Millions of US $)
2011-09-30 $5
2011-06-30 $5
2011-03-31 $5
2010-12-31 $5
2010-09-30 $5
2010-06-30 $5
2010-03-31 $5
2009-12-31 $5
2009-09-30 $5
2009-06-30 $5
2009-03-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.013B $0.000B
Lotus Pharmaceuticals, Inc. operates, controls and owns the pharmaceutical businesses in China of Beijing Liang Fang Pharmaceutical Co., Ltd. and Beijing En Zhe Jia Shi Pharmaceutical Co., Ltd., collectively Lotus East. The Company believes Lotus East has some of the most advanced pharmaceutical production equipment in China and its manufacturing facilities meet national Good Manufacturing Practices. The Company distributes its own portfolio of drugs and pharmaceutical products produced by other manufacturers in the People's Republic of China through an extensive national distribution network. Liang Fang owns and operates drug stores throughout Beijing, China that sell Western and traditional Chinese medications and lease medical treatment facilities to licensed physicians. En Zhe Jia is a manufacturer for Liang Fang and maintains facilities for the production of medicines, Chinese medicine, as well as the research and production of other new medicines.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $78.506B 31.92
Chugai Pharmaceutical (CHGCY) Japan $50.534B 22.59
Takeda Pharmaceutical (TAK) Japan $41.333B 8.37
Merck (MKGAF) Germany $23.559B 22.84
Astellas Pharma (ALPMY) Japan $17.572B 27.74
Sandoz Group AG (SDZNY) Switzerland $15.150B 0.00
Neurocrine Biosciences (NBIX) United States $14.032B 38.41
Shionogi (SGIOY) Japan $12.692B 11.03
United Therapeutics (UTHR) United States $12.262B 13.07
Catalent (CTLT) United States $9.948B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.588B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.651B 7.31
Revolution Medicines (RVMD) United States $6.562B 0.00
Orion OYJ (ORINY) Finland $5.645B 23.81
Ionis Pharmaceuticals (IONS) United States $5.547B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.396B 0.00
Madrigal Pharmaceuticals (MDGL) United States $5.009B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.986B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.122B 0.00
Summit Therapeutics (SMMT) United States $3.082B 0.00
Corcept Therapeutics (CORT) United States $2.980B 27.00
PTC Therapeutics (PTCT) United States $2.964B 0.00
Dyne Therapeutics (DYN) United States $2.755B 0.00
Indivior (INDV) United States $2.311B 10.95
Recursion Pharmaceuticals (RXRX) United States $2.196B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.053B 11.67
Catalyst Pharmaceuticals (CPRX) United States $1.906B 18.55
Evotec AG (EVO) Germany $1.832B 0.00
Fusion Pharmaceuticals (FUSN) Canada $1.830B 0.00
Ardelyx (ARDX) United States $1.820B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.762B 0.00
Taro Pharmaceutical Industries (TARO) Israel $1.608B 24.17
Avadel Pharmaceuticals (AVDL) Ireland $1.521B 0.00
Xencor (XNCR) United States $1.511B 0.00
Soleno Therapeutics (SLNO) United States $1.432B 0.00
Pacira BioSciences (PCRX) United States $1.430B 13.59
BioCryst Pharmaceuticals (BCRX) United States $1.374B 0.00
4D Molecular Therapeutics (FDMT) United States $1.352B 0.00
Collegium Pharmaceutical (COLL) United States $1.118B 6.69
Enliven Therapeutics (ELVN) United States $1.077B 0.00
Cronos Group (CRON) Canada $1.066B 0.00
Cassava Sciences (SAVA) United States $1.061B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.016B 15.83
Relay Therapeutics (RLAY) United States $1.000B 0.00
Ocular Therapeutix (OCUL) United States $0.929B 0.00
USANA Health Sciences (USNA) United States $0.925B 15.13
Centessa Pharmaceuticals (CNTA) United Kingdom $0.879B 0.00
ARS Pharmaceuticals (SPRY) United States $0.865B 0.00
ProKidney (PROK) United States $0.830B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.789B 0.00
Sage Therapeutics (SAGE) United States $0.728B 0.00
Lyell Immunopharma (LYEL) United States $0.704B 0.00
Silence Therapeutics (SLN) United Kingdom $0.695B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.647B 0.00
Harrow (HROW) United States $0.609B 0.00
Exscientia (EXAI) United Kingdom $0.598B 0.00
Savara (SVRA) United States $0.598B 0.00
Altimmune (ALT) United States $0.559B 0.00
Siga Technologies (SIGA) United States $0.532B 6.80
Heron Therapeutics (HRTX) United States $0.523B 0.00
OmniAb (OABI) United States $0.518B 0.00
Larimar Therapeutics (LRMR) United States $0.504B 0.00
Lexeo Therapeutics (LXEO) United States $0.499B 0.00
Bioventus (BVS) United States $0.499B 19.09
KalVista Pharmaceuticals (KALV) United States $0.493B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.480B 0.00
Verve Therapeutics (VERV) United States $0.470B 0.00
Korro Bio (KRRO) United States $0.466B 0.00
Esperion Therapeutics (ESPR) United States $0.451B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.437B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.384B 0.00
Organogenesis (ORGO) United States $0.374B 70.50
Fractyl Health (GUTS) United States $0.365B 0.00
Tourmaline Bio (TRML) United States $0.350B 0.00
Nektar Therapeutics (NKTR) United States $0.321B 0.00
Xeris Biopharma Holdings (XERS) United States $0.298B 0.00
Nanobiotix S.A (NBTX) France $0.293B 0.00
Nature's Sunshine Products (NATR) United States $0.292B 18.57
Aquestive Therapeutics (AQST) United States $0.287B 0.00
Black Diamond Therapeutics (BDTX) United States $0.284B 0.00
ESSA Pharma (EPIX) Canada $0.275B 0.00
Century Therapeutics (IPSC) United States $0.273B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.271B 0.00
Metagenomi (MGX) United States $0.269B 0.00
Foghorn Therapeutics (FHTX) United States $0.265B 0.00
Acrivon Therapeutics (ACRV) United States $0.265B 0.00
CytoDyn (CYDY) United States $0.238B 0.00
Akebia Therapeutics (AKBA) United States $0.231B 0.00
Aldeyra Therapeutics (ALDX) United States $0.230B 0.00
Pyxis Oncology (PYXS) United States $0.230B 0.00
Eliem Therapeutics (ELYM) United States $0.229B 0.00
Prelude Therapeutics (PRLD) United States $0.226B 0.00
Avita Medical (RCEL) United States $0.220B 0.00
Conduit Pharmaceuticals (CDT) United States $0.219B 0.00
Adherex Technologies (FENC) United States $0.196B 239.67
Zevra Therapeutics (ZVRA) United States $0.194B 0.00
Galectin Therapeutics (GALT) United States $0.193B 0.00
Profound Medical (PROF) Canada $0.193B 0.00
Achieve Life Sciences (ACHV) Canada $0.177B 0.00
Innate Pharma SA (IPHYF) France $0.176B 0.00
VAXART, INC (VXRT) United States $0.176B 0.00
Incannex Healthcare (IXHL) Australia $0.171B 0.00
MediWound (MDWD) Israel $0.167B 0.00
Telomir Pharmaceuticals (TELO) United States $0.166B 0.00
Elite Pharmaceuticals (ELTP) United States $0.164B 15.39
Rigel Pharmaceuticals (RIGL) United States $0.162B 0.00
Cardiol Therapeutics (CRDL) Canada $0.149B 0.00
Context Therapeutics (CNTX) United States $0.146B 0.00
Citius Pharmaceuticals (CTXR) United States $0.134B 0.00
OptiNose (OPTN) United States $0.131B 0.00
Karyopharm Therapeutics (KPTI) United States $0.131B 0.00
Regulus Therapeutics (RGLS) United States $0.126B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.124B 8.32
FibroGen (FGEN) United States $0.122B 0.00
PMV Pharmaceuticals (PMVP) United States $0.109B 0.00
Assertio Holdings (ASRT) United States $0.099B 4.52
ProPhase Labs (PRPH) United States $0.098B 0.00
Vivani Medical (VANI) United States $0.097B 0.00
SCYNEXIS (SCYX) United States $0.096B 1.35
Relmada Therapeutics (RLMD) United States $0.093B 0.00
AlloVir (ALVR) United States $0.090B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.086B 0.00
Aclaris Therapeutics (ACRS) United States $0.082B 0.00
Tempest Therapeutics (TPST) United States $0.073B 0.00
Journey Medical (DERM) United States $0.071B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.071B 0.00
Mural Oncology (MURA) Ireland $0.064B 0.00
Champions Oncology (CSBR) United States $0.064B 0.00
Protara Therapeutics (TARA) United States $0.062B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.061B 0.00
Carisma Therapeutics (CARM) United States $0.059B 0.00
Nutriband (NTRB) United States $0.053B 0.00
Inotiv (NOTV) United States $0.053B 0.00
BioLineRx (BLRX) Israel $0.050B 0.00
CASI Pharmaceuticals (CASI) China $0.046B 0.00
Gain Therapeutics (GANX) United States $0.044B 0.00
ElectroCore (ECOR) United States $0.042B 0.00
NRx Pharmaceuticals (NRXP) United States $0.042B 0.00
Natural Alternatives (NAII) United States $0.041B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.040B 0.00
VYNE Therapeutics (VYNE) United States $0.039B 0.00
Rafael Holdings (RFL) United States $0.039B 0.00
DURECT (DRRX) United States $0.038B 0.00
Jaguar Animal Health (JAGX) United States $0.038B 0.00
Unicycive Therapeutics (UNCY) United States $0.038B 0.00
Lipocine (LPCN) United States $0.035B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.035B 0.00
Surrozen (SRZN) United States $0.034B 0.00
Viracta Therapeutics (VIRX) United States $0.030B 0.00
JanOne (JAN) United States $0.030B 0.00
BioVie (BIVI) United States $0.030B 0.00
Enlivex Therapeutics (ENLV) Israel $0.027B 0.00
Oncternal Therapeutics (ONCT) United States $0.027B 0.00
TherapeuticsMD (TXMD) United States $0.025B 0.00
Iterum Therapeutics (ITRM) Ireland $0.024B 0.00
PolyPid (PYPD) Israel $0.022B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.022B 0.00
MEI Pharma (MEIP) United States $0.021B 0.81
Indaptus Therapeutics (INDP) United States $0.021B 0.00
Aptorum Group (APM) United Kingdom $0.021B 0.00
Lyra Therapeutics (LYRA) United States $0.021B 0.00
GlycoMimetics (GLYC) United States $0.018B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.018B 0.00
Nuvilex (PMCB) United States $0.018B 0.00
Minerva Neurosciences (NERV) United States $0.017B 0.00
Talphera (TLPH) United States $0.017B 0.00
Alaunos Therapeutics (TCRT) United States $0.017B 0.00
Traws Pharma (TRAW) United States $0.016B 0.00
CERo Therapeutics Holdings (CERO) United States $0.015B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.014B 0.00
Mannatech (MTEX) United States $0.014B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.014B 0.00
Redhill Biopharma (RDHL) Israel $0.014B 0.00
Dominari Holdings (DOMH) United States $0.013B 0.00
Plus Therapeutics (PSTV) United States $0.012B 0.00
Inhibikase Therapeutics (IKT) United States $0.012B 0.00
Cosmos Health (COSM) Greece $0.012B 0.00
Mangoceuticals (MGRX) United States $0.011B 0.00
Avalo Therapeutics (AVTX) United States $0.011B 0.00
Biomerica (BMRA) United States $0.011B 0.00
TransCode Therapeutics (RNAZ) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Universe Pharmaceuticals INC (UPC) China $0.009B 0.00
Molecular Templates (MTEM) United States $0.009B 0.00
SHINECO (SISI) China $0.008B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
Vivos Therapeutics (VVOS) United States $0.007B 0.00
Ainos (AIMD) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Heatwurx (PCSA) United States $0.005B 0.00
XORTX Therapeutics (XRTX) Canada $0.005B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.005B 0.00
Petros Pharmaceuticals (PTPI) United States $0.005B 0.00
Phio Pharmaceuticals (PHIO) United States $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
Bio-Path Holdings (BPTH) United States $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.003B 0.00
Finch Therapeutics (FNCH) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.38
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 32.86